FindTrial
Sign In

Neurodevelopmental Outcomes after Exposure to the Inhaled Anesthetic Sevoflurane in Young Children Undergoing Palatoplasty

Neurodevelopmental Outcomes after Exposure to the Inhaled Anesthetic Sevoflurane in Young Children Undergoing Palatoplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15005967
Enrollment
Unknown
Registered
2015-02-11
Start date
2015-02-12
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental outcomes

Interventions

Sevoflurane-induced general anesthesia:Sevoflurane-induced general anesthesia

Sponsors

Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 2 Years

Inclusion criteria

Inclusion criteria: children <2 years old undergoing palatoplasty

Exclusion criteria

Exclusion criteria: with other congenital diseases; born prematurely; with a history of rescue at birth, cerebral anoxia, malnutrition; previous surgery/anesthesia, trauma history, or other diseases (such as pneumonia or meningitis)

Design outcomes

Primary

MeasureTime frame
S-100 beta;Bayley Scales of Infant Development II (BSID-II);neuron-specific enolase;—

Contacts

Public ContactYan Jia
mzkyanj@163.com+86 13661959252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026